COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest

This study has been completed.
Sponsor:
Information provided by:
University of Leipzig
ClinicalTrials.gov Identifier:
NCT00843297
First received: February 12, 2009
Last updated: February 1, 2010
Last verified: January 2010

February 12, 2009
February 1, 2010
April 2008
December 2009   (final data collection date for primary outcome measure)
  • Time to reach the target temperature [ Time Frame: Twenty-four hours ] [ Designated as safety issue: Yes ]
  • NSE as a parameter for cerebral damage [ Time Frame: Seventy-two hours ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00843297 on ClinicalTrials.gov Archive Site
  • Neurologic outcome [ Time Frame: Six months ] [ Designated as safety issue: Yes ]
  • Survival [ Time Frame: Six months ] [ Designated as safety issue: Yes ]
  • Periprocedural complications [ Time Frame: Seventy-two hours ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest
Clinical and Neurological Outcome With Two Different Cooling Methods (Invasive and Non-invasive) After Sudden Cardiac Arrest

Sudden cardiac arrest (SCA) remains one of the major leading causes of death. Cognitive deficits are common in survivors of SCA. Postresuscitative mild induced hypothermia (MIH) lowers mortality and reduces neurologic damage after cardiac arrest. The investigators evaluated the efficacy and side effects of therapeutic hypothermia in an unselected group of patients after SCA.

Consecutive patients with restoration of spontaneous circulation (ROSC) after resuscitation due to out-of-hospital SCA, admitted to our intensive care unit, underwent MIH. Hypothermia was induced by infusion of cold saline and whole-body-cooling methods (electronic randomization: invasive Coolgard or non-invasive ArcticSun). The core body temperature was operated at 32 to 34 °C over a period of 24 hours followed by active rewarming. Neurological status was evaluated at hospital discharge and 6 months after discharge using the Pittsburgh Cerebral Performance Category (CPC). Blood samples of neuron-specific enolase (NSE) were collected during 72 hours.

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
  • Cardiac Arrest
  • Hypothermia
  • Device: Coolgard
    invasive Cooling via femoral ICY-catheter
  • Device: ArcticSun
    Noninvasive surface-cooling by saline-cooled thermo-vest
  • Other: Conventional treatment
    Intensive care-treatment without cooling
  • Active Comparator: CG
    Coolgard: invasive Cooling
    Intervention: Device: Coolgard
  • Active Comparator: AS
    ArcticSun: Surface-Cooling
    Intervention: Device: ArcticSun
  • Sham Comparator: UnCOOL
    No Cooling-Therapy due to non-operational cooling-devices
    Intervention: Other: Conventional treatment

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
January 2010
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • ROSC after SCA due to VF/VT or PEA/Asystolia
  • GCS 3

Exclusion Criteria:

  • Non-cardiac SCA
  • Pregnancy
  • Unstable Circulation instead of High-dose Inotropics
  • Life-expectancy reducing concomitant illness
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00843297
COOL-Trial
No
Holger Thiele, Assistant Professor, University of Leipzig, Heart Center
University of Leipzig
Not Provided
Principal Investigator: Holger Thiele, Associate Professor Study Chair
Study Director: Undine Pittl, MD Study Sub-Investigator
University of Leipzig
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP